Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 15 studies | 59% ± 22% | |
oligodendrocyte precursor cell | 11 studies | 38% ± 16% | |
oligodendrocyte | 11 studies | 29% ± 12% | |
pericyte | 10 studies | 29% ± 9% | |
basal cell | 9 studies | 32% ± 12% | |
ciliated cell | 9 studies | 29% ± 7% | |
endothelial cell | 8 studies | 36% ± 18% | |
epithelial cell | 7 studies | 38% ± 14% | |
club cell | 6 studies | 32% ± 10% | |
fibroblast | 6 studies | 26% ± 9% | |
smooth muscle cell | 6 studies | 29% ± 13% | |
retinal pigment epithelial cell | 4 studies | 27% ± 6% | |
myofibroblast cell | 3 studies | 16% ± 1% | |
ependymal cell | 3 studies | 61% ± 13% | |
respiratory goblet cell | 3 studies | 49% ± 12% | |
group 3 innate lymphoid cell | 3 studies | 19% ± 3% | |
myoepithelial cell | 3 studies | 44% ± 18% | |
kidney loop of Henle epithelial cell | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2373.20 | 245 / 245 | 99% | 18.33 | 498 / 502 |
thymus | 100% | 5023.42 | 653 / 653 | 99% | 64.72 | 599 / 605 |
kidney | 100% | 2487.72 | 89 / 89 | 99% | 20.44 | 892 / 901 |
ovary | 100% | 3944.43 | 180 / 180 | 95% | 18.81 | 410 / 430 |
brain | 95% | 3048.57 | 2518 / 2642 | 100% | 61.58 | 702 / 705 |
breast | 99% | 3136.66 | 455 / 459 | 93% | 14.85 | 1040 / 1118 |
bladder | 100% | 1380.14 | 21 / 21 | 91% | 14.07 | 461 / 504 |
lung | 99% | 1546.81 | 573 / 578 | 90% | 13.12 | 1040 / 1155 |
intestine | 100% | 1967.07 | 966 / 966 | 89% | 10.13 | 469 / 527 |
uterus | 100% | 4104.25 | 170 / 170 | 86% | 11.84 | 396 / 459 |
stomach | 97% | 1170.27 | 350 / 359 | 84% | 8.63 | 241 / 286 |
esophagus | 99% | 1616.44 | 1437 / 1445 | 77% | 7.57 | 140 / 183 |
skin | 100% | 2885.08 | 1806 / 1809 | 75% | 11.49 | 355 / 472 |
liver | 97% | 1201.15 | 219 / 226 | 73% | 6.52 | 296 / 406 |
pancreas | 64% | 423.72 | 209 / 328 | 97% | 14.97 | 173 / 178 |
adrenal gland | 100% | 1726.78 | 258 / 258 | 20% | 2.35 | 47 / 230 |
blood vessel | 100% | 2553.22 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 1632.54 | 1194 / 1204 | 0% | 0 | 0 / 0 |
heart | 91% | 975.58 | 784 / 861 | 0% | 0 | 0 / 0 |
spleen | 87% | 686.52 | 209 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 10.63 | 37 / 45 |
lymph node | 0% | 0 | 0 / 0 | 48% | 3.35 | 14 / 29 |
eye | 0% | 0 | 0 / 0 | 28% | 2.53 | 22 / 80 |
peripheral blood | 19% | 255.59 | 175 / 929 | 0% | 0 | 0 / 0 |
muscle | 18% | 119.29 | 147 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005881 | Cellular component | cytoplasmic microtubule |
GO_0005515 | Molecular function | protein binding |
GO_0042802 | Molecular function | identical protein binding |
Gene name | GRAMD2B |
Protein name | GRAM domain-containing protein 2B (HCV NS3-transactivated protein 2) GRAM domain containing 2B Alternative protein GRAMD3 GRAM domain containing 2B (cDNA FLJ50592, highly similar to GRAM domain-containing protein 3) |
Synonyms | GRAMD3 NS3TP2 |
Description | |
Accessions | ENST00000506445.5 D6RFH3 Q96HH9 E9PD09 ENST00000285689.8 [Q96HH9-1] D6R9P9 ENST00000544396.5 [Q96HH9-5] ENST00000513040.5 [Q96HH9-3] ENST00000502348.5 D6REP5 ENST00000542322.5 [Q96HH9-2] ENST00000514099.5 ENST00000513978.5 L8EAD1 ENST00000515200.5 ENST00000511134.1 [Q96HH9-4] B7Z4W8 |